Ishfaq, M.; Pham, T.; Beaman, C.; Tamayo, P.; Yu, A.L.; Joshi, S.
BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma. Cancers 2021, 13, 817.
https://doi.org/10.3390/cancers13040817
AMA Style
Ishfaq M, Pham T, Beaman C, Tamayo P, Yu AL, Joshi S.
BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma. Cancers. 2021; 13(4):817.
https://doi.org/10.3390/cancers13040817
Chicago/Turabian Style
Ishfaq, Mehreen, Timothy Pham, Cooper Beaman, Pablo Tamayo, Alice L. Yu, and Shweta Joshi.
2021. "BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma" Cancers 13, no. 4: 817.
https://doi.org/10.3390/cancers13040817
APA Style
Ishfaq, M., Pham, T., Beaman, C., Tamayo, P., Yu, A. L., & Joshi, S.
(2021). BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma. Cancers, 13(4), 817.
https://doi.org/10.3390/cancers13040817